AEON Biopharma Stockholders Approve Key Proposals

AEON Biopharma ( (AEON) ) just unveiled an update.

At a recent Special Meeting, AEON Biopharma’s stockholders approved several key proposals. These included an amendment to increase the number of authorized shares of Common Stock, granting the board discretionary authority for a reverse stock split, authorizing the issuance of warrants and shares in compliance with NYSE American listing rules, and approving potential adjournments to solicit additional proxies if needed. These decisions are poised to impact the company’s capital structure and market operations significantly.

More about AEON Biopharma

YTD Price Performance: -78.14%

Average Trading Volume: 18,494,218

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $9.62M

Find detailed analytics on AEON stock on TipRanks’ Stock Analysis page.